v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
License and collaboration revenue $ 1,000   $ 1,000 $ 10,000
Total revenue 1,000   1,000 10,000
Operating expenses:        
Research and development 62,913 $ 43,027 123,352 77,942
General and administrative 15,746 12,136 32,657 24,551
Acquired in-process research and development 30,000   30,000  
Total operating expenses 108,659 55,163 186,009 102,493
Loss from operations (107,659) (55,163) (185,009) (92,493)
Other income (expense), net:        
Interest expense on royalty obligation (6,837)   (13,100)  
Interest expense on senior secured term loan (1,720)   (2,088)  
Interest expense on convertible senior notes (1,745)   (1,745)  
Interest income 6,603 2,743 9,621 6,136
Other income (expense), net 16 217 (8) 376
Total other income (expense), net (3,683) 2,960 (7,320) 6,512
Loss before income taxes (111,342) (52,203) (192,329) (85,981)
Income tax provision (benefit) 114 20 114 (185)
Net loss $ (111,456) $ (52,223) $ (192,443) $ (85,796)
Net loss per share - basic (in dollars per share) $ (1.77) $ (1.25) $ (3.24) $ (2.05)
Net loss per share - diluted (in dollars per share) $ (1.77) $ (1.25) $ (3.24) $ (2.05)
Weighted-average common stock outstanding - basic (in shares) 63,112,314 41,865,400 59,393,300 41,833,279
Weighted-average common stock outstanding - diluted (in shares) 63,112,314 41,865,400 59,393,300 41,833,279
Comprehensive loss:        
Net loss $ (111,456) $ (52,223) $ (192,443) $ (85,796)
Other comprehensive income (loss):        
Unrealized (loss) gain on investments (780) 30 (1,121) 42
Foreign currency translation adjustment 16 (265) 44 (330)
Comprehensive loss $ (112,220) $ (52,458) $ (193,520) $ (86,084)